Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?

Detalles Bibliográficos
Autores principales: Chen, Xinyang, Li, Hancong, Feng, Qingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007952/
https://www.ncbi.nlm.nih.gov/pubmed/36915434
http://dx.doi.org/10.21037/jgo-22-1128
_version_ 1784905646606385152
author Chen, Xinyang
Li, Hancong
Feng, Qingbo
author_facet Chen, Xinyang
Li, Hancong
Feng, Qingbo
author_sort Chen, Xinyang
collection PubMed
description
format Online
Article
Text
id pubmed-10007952
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-100079522023-03-12 Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib? Chen, Xinyang Li, Hancong Feng, Qingbo J Gastrointest Oncol Letter to the Editor AME Publishing Company 2023-01-16 2023-02-28 /pmc/articles/PMC10007952/ /pubmed/36915434 http://dx.doi.org/10.21037/jgo-22-1128 Text en 2023 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Letter to the Editor
Chen, Xinyang
Li, Hancong
Feng, Qingbo
Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
title Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
title_full Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
title_fullStr Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
title_full_unstemmed Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
title_short Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
title_sort is neutrophil-to-lymphocyte ratio and c-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007952/
https://www.ncbi.nlm.nih.gov/pubmed/36915434
http://dx.doi.org/10.21037/jgo-22-1128
work_keys_str_mv AT chenxinyang isneutrophiltolymphocyteratioandcreactiveproteintheprognosticroleinmetastaticcolorectalcancerusingregorafenib
AT lihancong isneutrophiltolymphocyteratioandcreactiveproteintheprognosticroleinmetastaticcolorectalcancerusingregorafenib
AT fengqingbo isneutrophiltolymphocyteratioandcreactiveproteintheprognosticroleinmetastaticcolorectalcancerusingregorafenib

Ejemplares similares